Skip to main content

Gemcitabine hydrochloride

NDC 82511-009 · Teyro Labs Private Limited

Generic nameGemcitabine hydrochloride
Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
RouteINTRAVENOUS
Active ingredient(s)GEMCITABINE HYDROCHLORIDE
Strength1 g/25mL
Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
Marketing categoryANDA

Packages

82511-009-10 — 1 VIAL, SINGLE-USE in 1 CARTON (82511-009-10) / 25 mL in 1 VIAL, SINGLE-USE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

25021-239 — gemcitabine, 55111-686 — gemcitabine, 55111-687 — gemcitabine, 63323-102 — GEMCITABINE, 63323-125 — GEMCITABINE, 63323-126 — GEMCITABINE, 67457-616 — GEMCITABINE HYDROCHLORIDE, 67457-617 — GEMCITABINE HYDROCHLORIDE, 67457-618 — GEMCITABINE HYDROCHLORIDE, 68001-342 — GEMCITABINE, 68001-348 — GEMCITABINE, 68001-359 — GEMCITABINE, 68083-148 — gemcitabine hydrochloride, 68083-149 — gemcitabine hydrochloride, 71288-113 — GEMCITABINE HYDROCHLORIDE, 71288-114 — GEMCITABINE HYDROCHLORIDE, 71288-117 — Gemcitabine hydrochloride, 82511-008 — Gemcitabine hydrochloride, 83831-123 — Gemcitabine, 83831-124 — Gemcitabine, +13 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels